Peter P Stanich
Overview
Explore the profile of Peter P Stanich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hodan R, Gupta S, Weiss J, Axell L, Burke C, Chen L, et al.
J Natl Compr Canc Netw
. 2024 Dec;
22(10):695-711.
PMID: 39689429
Multigene panel testing has allowed for the detection of a growing number of inherited pathogenic/likely pathogenic variants in people at high risk of cancer, including endometrial cancer (EC). Hereditary syndromes...
2.
Ness R, Llor X, Abbass M, Bishu S, Chen C, Cooper G, et al.
J Natl Compr Canc Netw
. 2024 Sep;
22(7):438-446.
PMID: 39236750
The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC....
3.
Ramsey M, Heald B, Gokun Y, Baker J, Groce J, Han S, et al.
PLoS One
. 2024 Aug;
19(8):e0307076.
PMID: 39172977
Background/objectives: Germline genetic testing is recommended for younger patients with idiopathic pancreatitis but there has been a lack of consensus in recommendations for those over age 35. We aimed to...
4.
Karloski E, Dudley B, Diergaarde B, Blanco A, Everett J, Levinson E, et al.
Cancer
. 2024 May;
130(19):3297-3304.
PMID: 38809542
Background: Pancreatic ductal adenocarcinoma (PDAC) surveillance is recommended for some individuals with a pathogenic or likely pathogenic variant (PV/LPV) in a PDAC susceptibility gene; the recommendation is often dependent on...
5.
Stanich P, Katona B
J Clin Gastroenterol
. 2023 Nov;
58(2):107-108.
PMID: 37983757
No abstract available.
6.
Jain A, Alimirah M, Hampel H, Pearlman R, Ma J, Peng J, et al.
Front Oncol
. 2023 Apr;
12:1038678.
PMID: 37078003
Background: Lynch syndrome has not traditionally been considered to have a high colorectal adenoma burden. However, with increasing adenoma detection rates in the general population, the incidence of adenoma detection...
7.
Freitag C, Chen W, Pearlman R, Hampel H, Stanich P, Cosgrove C, et al.
Hum Pathol
. 2023 Apr;
137:1-9.
PMID: 37030500
Mismatch repair (MMR) protein-deficient non-neoplastic colonic crypts and endometrial glands (dMMR crypts and glands) have been reported as a unique marker of underlying Lynch syndrome (LS). However, no large studies...
8.
Cavestro G, Mannucci A, Balaguer F, Hampel H, Kupfer S, Repici A, et al.
Clin Gastroenterol Hepatol
. 2022 Dec;
21(3):581-603.e33.
PMID: 36549470
Background & Aims: Patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), composed of 69 experts, was convened to...
9.
Long J, Ebrahimzadeh J, Stanich P, Katona B
Cancer Manag Res
. 2022 Oct;
14:2953-2969.
PMID: 36238953
Gastric cancer is one of the most significant causes of cancer-related morbidity and mortality worldwide. Recognized modifiable risk factors include infection, geographic location, select dietary factors, tobacco use and alcohol...
10.
Stanich P, Elgindi D, Stoffel E, Koeppe E, Bansal A, Stetson R, et al.
Am J Gastroenterol
. 2022 Sep;
117(11):1877-1879.
PMID: 36087100
Introduction: Germline variants in CDH1 are associated with elevated risks of diffuse gastric cancer and lobular breast cancer. It is uncertain whether there is an increased risk of colorectal neoplasia....